Telerehabilitation After Spine Surgery

NCT07795697 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-08-31

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to assess how different methods of delivering post-operative instructions affect the participants' recovery after spinal decompression surgery. In addition, the investigators evaluate the related healthcare costs and the use of healthcare services in both working-age and elderly populations. The main research questions of the study are:

1. Does the method or timing of post-operative information influence healthcare utilization or recovery after surgery?
2. Are telerehabilitation methods easily accessible and usable for the elderly population?
3. Does early intervention provided in the hospital lead to different recovery times after surgery?

The outcome measures include pain levels, daily activity levels, and healthcare utilization. The results will be compared between study groups based on the information delivery method and age group.

Conditions

  • Spine Surgery
  • Telerehabilitation
  • Low Back Pain

Interventions

PROCEDURE

Telerehabilitation method

Rehabilitation instrucions given by physiotherapist 4-7 days after surgery with remote telerehabilitation method

PROCEDURE

Nurse instructions

Nurse gives the patient rehabilitation instructions after surgery when the subject leaves hospital

PROCEDURE

Physiotherapy after surgery, personal

Physiotherapist gives the patient rehabilitation instructions after surgery when the subject leaves hospital

PROCEDURE

Hospital physioterapy

Physiotherapist gives the patient rehabilitation instructions at the hospital outpatient clinic after 4-7 days post-operatively

Sponsors & Collaborators

  • Kuopio University Hospital

    lead OTHER

Principal Investigators

  • Janne Pesonen, MD, PhD · Kuopio University Hospital; Department of Rehabilitation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2029-12-31
Completion
2029-12-31

Countries

  • Finland

Study Locations

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07795697 on ClinicalTrials.gov